Ligand validation:7FRF

6SU: methyl 3-(methylsulfonylamino)benzoate

6SU is a Ligand Of Interest in 7FRF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7FRF_6SU_A_702	1%	6%	0.438	0.617	2.22	2.84	6	6	0	0	100%	0.39
5QDR_6SU_A_401	0%	15%	1.341	0.192	2.14	1.65	4	4	0	0	100%	9
5KH6_6SU_A_513	61%	86%	0.141	0.93	0.37	0.34	-	-	0	0	100%	1
5S9Y_6SU_A_509	52%	85%	0.149	0.907	0.26	0.47	-	-	0	0	100%	0.86
5SO0_6SU_A_501	24%	5%	0.218	0.849	2.24	3.18	3	5	0	0	100%	0.76
5R59_6SU_A_401	24%	84%	0.239	0.869	0.3	0.46	-	-	0	0	100%	0.56
5QJJ_6SU_D_303	18%	6%	0.167	0.754	2.58	2.48	6	6	0	0	100%	0.86

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.